6.
Albu S, Rivas Zozaya N, Murillo N, Garcia-Molina A, Figueroa Chacon C, Kumru H
. What's going on following acute covid-19? Clinical characteristics of patients in an out-patient rehabilitation program. NeuroRehabilitation. 2021; 48(4):469-480.
DOI: 10.3233/NRE-210025.
View
7.
Garg R, Paliwal V
. Spectrum of neurological complications following COVID-19 vaccination. Neurol Sci. 2021; 43(1):3-40.
PMC: 8557950.
DOI: 10.1007/s10072-021-05662-9.
View
8.
Nonnekes J, Ruzicka E, Serranova T, Reich S, Bloem B, Hallett M
. Functional gait disorders: A sign-based approach. Neurology. 2020; 94(24):1093-1099.
PMC: 7455329.
DOI: 10.1212/WNL.0000000000009649.
View
9.
Tinazzi M, Geroin C, Erro R, Marcuzzo E, Cuoco S, Ceravolo R
. Functional motor disorders associated with other neurological diseases: Beyond the boundaries of "organic" neurology. Eur J Neurol. 2020; 28(5):1752-1758.
DOI: 10.1111/ene.14674.
View
10.
Walzl D, Solomon A, Stone J
. Functional neurological disorder and multiple sclerosis: a systematic review of misdiagnosis and clinical overlap. J Neurol. 2021; 269(2):654-663.
PMC: 8782816.
DOI: 10.1007/s00415-021-10436-6.
View
11.
Takahashi O, Sakakibara R, Sawai S, Ogata T
. Functional neurological disorders after COVID-19 vaccination: Case series and literature review. Psychiatry Clin Neurosci. 2022; 76(10):529-531.
PMC: 9350106.
DOI: 10.1111/pcn.13453.
View
12.
Hallett M, Aybek S, Dworetzky B, McWhirter L, Staab J, Stone J
. Functional neurological disorder: new subtypes and shared mechanisms. Lancet Neurol. 2022; 21(6):537-550.
PMC: 9107510.
DOI: 10.1016/S1474-4422(21)00422-1.
View
13.
Hallett M
. Physiology of psychogenic movement disorders. J Clin Neurosci. 2010; 17(8):959-65.
PMC: 2902582.
DOI: 10.1016/j.jocn.2009.11.021.
View
14.
Butler M, Coebergh J, Safavi F, Carson A, Hallett M, Michael B
. Functional Neurological Disorder After SARS-CoV-2 Vaccines: Two Case Reports and Discussion of Potential Public Health Implications. J Neuropsychiatry Clin Neurosci. 2021; 33(4):345-348.
PMC: 8556318.
DOI: 10.1176/appi.neuropsych.21050116.
View
15.
Amanzio M, Mitsikostas D, Giovannelli F, Bartoli M, Cipriani G, Brown W
. Adverse events of active and placebo groups in SARS-CoV-2 vaccine randomized trials: A systematic review. Lancet Reg Health Eur. 2021; 12:100253.
PMC: 8553263.
DOI: 10.1016/j.lanepe.2021.100253.
View
16.
Piscitelli D, Perin C, Tremolizzo L, Peroni F, Cerri C, Cornaggia C
. Functional movement disorders in a patient with COVID-19. Neurol Sci. 2020; 41(9):2343-2344.
PMC: 7358315.
DOI: 10.1007/s10072-020-04593-1.
View
17.
de Souza A, Jacques R, Mohan S
. Vaccine-Induced Functional Neurological Disorders in the Covid-19 Era. Can J Neurol Sci. 2022; 50(3):346-350.
DOI: 10.1017/cjn.2022.48.
View
18.
Zepeda R, Lee Y, Agostini M, Alick Lindstrom S, Dave H, Dieppa M
. Emergent Admissions to the Epilepsy Monitoring Unit in the Setting of COVID-19 Pandemic-related, State-mandated Restrictions: Clinical Decision Making and Outcomes. Neurodiagn J. 2021; 61(2):95-103.
DOI: 10.1080/21646821.2021.1918512.
View
19.
Nistico V, Goeta D, Gambini O, Demartini B
. The psychological impact of COVID-19 among a sample of Italian patients with functional neurological disorders: A preliminary study. Parkinsonism Relat Disord. 2020; 78:79-81.
PMC: 7374122.
DOI: 10.1016/j.parkreldis.2020.07.019.
View
20.
Albu S, Guven Z, Valles M, Kumru H
. Functional neurological disorders in post COVID-19 patients. Case series. Neurologia (Engl Ed). 2022; 38(1):56-57.
PMC: 9714180.
DOI: 10.1016/j.nrleng.2021.12.005.
View